United Medical Capital
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
44/100
Moderate Influence
$1.9M
Total Lobby Spend
5
Policy Issues
1
Lobbyists
0
Revolving Door
United Medical Capital reported $1.9 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Homeland Security
Dept of Energy
White House
Food & Drug Administration
Centers for Medicare & Medicaid Services
Environmental Protection Agency
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Cassidy & Associates LLP | LBR | 1 | $58K |
| 2020 Apr-Jun | Brownstein Hyatt LLP | HCRPHA | 1 | $73K |
| 2020 Jul-Sep | K&L Gates LLP | HCRPHALBR | 1 | $77K |
| 2020 Oct-Dec | K&L Gates LLP | LBRPHAMED | 1 | $56K |
| 2021 Jan-Mar | Brownstein Hyatt LLP | MEDGOV | 1 | $56K |
| 2021 Apr-Jun | Covington & Burling LLP | PHA | 1 | $90K |
| 2021 Jul-Sep | Cassidy & Associates LLP | GOVMEDHCR+2 | 1 | $65K |
| 2021 Oct-Dec | Covington & Burling LLP | PHAGOV | 1 | $55K |